A relatively recent psychoactive drug, tentatively named "2c-b-pink," is receiving attention within niche communities. Initial reports suggest that it’s a variation of the well-known copyright phenethylamine 2c-b, though its specific chemical structure remains still unverified by regulatory bodies. Users describe experiencing shifted perception,